Overview

Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this open-label study is to give chronic severe pain patients with existing intrathecal pump systems access to ziconotide.
Phase:
Phase 3
Details
Lead Sponsor:
Elan Pharmaceuticals
Treatments:
omega-Conotoxins
Ziconotide